Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

Clinical trial NCT05186948 · TERMINATED

Trial details

NCT number: NCT05186948
Sponsor: Innodem Neurosciences
Status: TERMINATED
Study type: OBSERVATIONAL

Cancer-related Cognitive Impairment

Start date: 2022-03-30
Primary completion: 2025-01-20
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.